Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
02 2019
Historique:
received: 26 04 2018
accepted: 30 08 2018
pubmed: 8 9 2018
medline: 6 5 2020
entrez: 8 9 2018
Statut: ppublish

Résumé

To shed light onto the molecular basis of Philadelphia chromosome-positive acute lymphoblastic leukemia and to investigate the prognostic role of additional genomic lesions, we analyzed copy number aberrations using the Cytoscan HD Array in 116 newly diagnosed adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia enrolled in four different GIMEMA protocols, all based on a chemotherapy-free induction strategy. This analysis showed that patients with Philadelphia chromosome-positive acute lymphoblastic leukemia carry an average of 7.8 lesions/case, with deletions outnumbering gains (88%

Identifiants

pubmed: 30190342
pii: haematol.2018.196055
doi: 10.3324/haematol.2018.196055
pmc: PMC6355475
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

312-318

Informations de copyright

Copyright © 2019 Ferrata Storti Foundation.

Références

Haematologica. 2011 Apr;96(4):552-7
pubmed: 21193419
Haematologica. 2006 Mar;91(3):377-80
pubmed: 16531262
Bone Marrow Transplant. 2017 Dec;52(12):1592-1598
pubmed: 28581459
Haematologica. 2015 Jan;100(1):55-61
pubmed: 25261097
Blood. 2015 Jun 11;125(24):3711-9
pubmed: 25878120
Cancer Cell. 2011 Apr 12;19(4):484-97
pubmed: 21481790
Blood. 2014 Aug 28;124(9):1434-44
pubmed: 24957142
J Hematol Oncol. 2016 Apr 18;9:40
pubmed: 27090891
Blood. 2011 Dec 15;118(25):6521-8
pubmed: 21931113
Leukemia. 2016 Jan;30(1):32-8
pubmed: 26202931
Blood. 2013 Aug 15;122(7):1214-21
pubmed: 23836561
Cancer Genet. 2017 Oct;216-217:29-36
pubmed: 29025593
Blood. 2007 May 1;109(9):3676-8
pubmed: 17213285
Blood. 2002 Oct 1;100(7):2357-66
pubmed: 12239143
Haematologica. 2014 Jan;99(1):94-102
pubmed: 23975177
Nature. 2008 May 1;453(7191):110-4
pubmed: 18408710
Leuk Lymphoma. 2017 Dec;58(12):2895-2904
pubmed: 28482719
Blood. 2007 Feb 15;109(4):1408-13
pubmed: 17062730
Best Pract Res Clin Haematol. 2011 Dec;24(4):489-503
pubmed: 22127311
J Hematol Oncol. 2015 Oct 20;8:115
pubmed: 26487643
Br J Haematol. 2017 Aug;178(4):583-587
pubmed: 28439887
J Clin Oncol. 2018 Apr 20;36(12):1240-1249
pubmed: 29498923
Leuk Lymphoma. 2016 Oct;57(10):2298-306
pubmed: 26892479
Leukemia. 2004 Apr;18(4):693-702
pubmed: 15044926
Best Pract Res Clin Haematol. 2009 Sep;22(3):445-54
pubmed: 19959093
Biol Blood Marrow Transplant. 2017 Aug;23(8):1227-1228
pubmed: 28603068
Ann Hematol. 2009 Nov;88(11):1069-77
pubmed: 19277658
Haematologica. 2013 Nov;98(11):1702-10
pubmed: 23716539
Blood. 2008 Mar 1;111(5):2563-72
pubmed: 18156492
Blood. 2014 Mar 13;123(11):1691-8
pubmed: 24366361
Nature. 2007 Apr 12;446(7137):758-64
pubmed: 17344859
Oncotarget. 2016 Mar 22;7(12):13886-901
pubmed: 26883104
J Natl Cancer Inst. 1960 Jul;25:85-109
pubmed: 14427847
Leukemia. 2012 Nov;26(11):2367-74
pubmed: 22705993
Blood. 2009 Sep 3;114(10):2159-67
pubmed: 19589926
Leuk Lymphoma. 2018 Jan;59(1):146-154
pubmed: 28554259
Blood. 2013 Aug 29;122(9):1634-48
pubmed: 23794064
Lancet Oncol. 2015 Nov;16(15):1547-1555
pubmed: 26432046
Leukemia. 2009 Jul;23(7):1209-18
pubmed: 19242497
Blood. 2018 Mar 29;131(13):1464-1475
pubmed: 29348129
J Clin Oncol. 2009 Nov 1;27(31):5202-7
pubmed: 19770381
Blood. 2002 Mar 1;99(5):1536-43
pubmed: 11861265
J Clin Oncol. 2010 Aug 1;28(22):3644-52
pubmed: 20606084
Leukemia. 2007 Jun;21(6):1258-66
pubmed: 17443227
Blood. 2004 Nov 15;104(10):3028-37
pubmed: 15256423
Am J Hematol. 2017 Mar;92(3):238-243
pubmed: 28006851
Br J Haematol. 2012 Oct;159(1):78-81
pubmed: 22823211
N Engl J Med. 2009 Jan 29;360(5):470-80
pubmed: 19129520
Cancer. 2015 Nov 1;121(21):3809-17
pubmed: 26194343
Haematologica. 2016 Dec;101(12):1544-1552
pubmed: 27515250
Blood. 2014 Feb 6;123(6):843-50
pubmed: 24277073

Auteurs

Anna Lucia Fedullo (AL)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Monica Messina (M)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Loredana Elia (L)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Alfonso Piciocchi (A)

GIMEMA Data Center, Rome.

Valentina Gianfelici (V)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Alessia Lauretti (A)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Stefano Soddu (S)

GIMEMA Data Center, Rome.

Maria Cristina Puzzolo (MC)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Clara Minotti (C)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Felicetto Ferrara (F)

Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples.

Bruno Martino (B)

Hematology Unit, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria.

Patrizia Chiusolo (P)

Institute of Hematology, Catholic University, Rome.

Valeria Calafiore (V)

Division of Hematology, AOU Policlinico, University of Catania.

Stefania Paolini (S)

"L. and A. Seràgnoli" Institute of Hematology, University of Bologna.

Marco Vignetti (M)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.
GIMEMA Data Center, Rome.

Antonella Vitale (A)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome.

Anna Guarini (A)

Department of Molecular Medicine, Sapienza University, Rome, Italy.

Robin Foà (R)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome chiaretti@bce.uniroma1.it rfoa@bce.uniroma1.it.

Sabina Chiaretti (S)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome chiaretti@bce.uniroma1.it rfoa@bce.uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH